Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

MRVI

Maravai LifeSciences Holdings Inc

Apr 19 • 02:12PM ET

7.35

Dollar change -0.26
Percentage change -3.44	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VB VXF VBK IBB SCHA VHT IWR OMFL IWP

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.90	Insider Own	19.27%	Shs Outstand	132.23M	Perf Week	-12.52%
Market Cap	972.25M	Forward P/E	154.73	EPS next Y	0.05	Insider Trans	0.00%	Shs Float	106.81M	Perf Month	-10.28%
Income	-119.03M	PEG	-	EPS next Q	-0.03	Inst Own	85.97%	Short Float	4.79%	Perf Quarter	17.57%
Sales	288.94M	P/S	3.36	EPS this Y	-168.12%	Inst Trans	-0.48%	Short Ratio	1.85	Perf Half Y	2.20%
Book/sh	3.15	P/B	2.33	EPS next Y	332.37%	ROA	-6.31%	Short Interest	5.12M	Perf Year	-47.92%
Cash/sh	4.35	P/C	1.69	EPS next 5Y	-	ROE	-24.75%	52W Range	4.52 - 16.62	Perf YTD	12.19%
Dividend Est.	-	P/FCF	16.03	EPS past 5Y	-37.53%	ROI	-11.73%	52W High	-55.79%	Beta	0.07
Dividend TTM	-	Quick Ratio	7.41	Sales past 5Y	47.72%	Gross Margin	47.59%	52W Low	62.57%	ATR (14)	0.46
Dividend Ex-Date	-	Current Ratio	8.00	EPS Y/Y TTM	-153.82%	Oper. Margin	-2.50%	RSI (14)	39.20	Volatility	4.88% 5.50%
Employees	650	Debt/Eq	1.47	Sales Y/Y TTM	-67.28%	Profit Margin	-41.19%	Recom	1.58	Target Price	9.85
Option/Short	Yes / Yes	LT Debt/Eq	1.44	EPS Q/Q	-386.39%	Payout	-	Rel Volume	0.31	Prev Close	7.61
Sales Surprise	15.17%	EPS Surprise	186.96%	Sales Q/Q	-63.78%	Earnings	May 08 AMC	Avg Volume	2.76M	Price	7.35
SMA20	-11.86%	SMA50	-1.47%	SMA200	-8.99%	Trades		Volume	634,994	Change	-3.44%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-24	Initiated	Craig Hallum	Buy	$15
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$10 → $8
Aug-08-23	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
May-23-23	Downgrade	Credit Suisse	Outperform → Neutral	$18 → $14
May-09-23	Downgrade	Goldman	Buy → Neutral
Jan-05-23	Downgrade	UBS	Buy → Neutral	$20 → $16
Dec-14-22	Initiated	Deutsche Bank	Buy	$25
Dec-07-22	Initiated	RBC Capital Mkts	Outperform	$22
Nov-03-22	Downgrade	BofA Securities	Buy → Neutral	$32 → $17
Aug-25-22	Initiated	Credit Suisse	Outperform	$34
Aug-05-21	Resumed	Credit Suisse	Outperform	$44
Dec-16-20	Initiated	KeyBanc Capital Markets	Overweight	$33
Dec-15-20	Initiated	William Blair	Outperform
Dec-15-20	Initiated	Stifel	Buy	$31
Dec-15-20	Initiated	Robert W. Baird	Outperform	$31
Dec-15-20	Initiated	Jefferies	Buy
Dec-15-20	Initiated	Goldman	Buy	$38
Dec-15-20	Initiated	Credit Suisse	Outperform
Dec-15-20	Initiated	BofA Securities	Buy	$31
Dec-14-20	Initiated	UBS	Buy	$32

Show Previous Ratings

Apr-18-24 07:36AM	TriLink BioTechnologies Announces New San Diego Facility for Late Phase mRNA Drug Substance Production (Business Wire)
Apr-10-24 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, May 8, 2024 (GlobeNewswire)
Mar-28-24 04:00PM	Dyadic Reports 2023 Full Year Results and Recent Company Progress (GlobeNewswire)
Mar-19-24 07:48AM	Should You Sell Maravai LifeSciences (MRVI)? (Insider Monkey)
Mar-12-24 04:15PM	Maravai LifeSciences Announces March 2024 Investor Conference Schedule (GlobeNewswire)
12:15PM	Loading…
Feb-23-24 12:15PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript (Insider Monkey) +63.60%
10:10AM	Q4 2023 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-22-24 08:30PM	Maravai LifeSciences (MRVI) Q4 2023 Earnings Call Transcript (Motley Fool)
04:43PM	Maravai LifeSciences Holdings Inc (MRVI) Faces Net Loss in 2023 Despite Revenue Outperformance (GuruFocus.com)
04:05PM	Maravai LifeSciences Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Feb-21-24 08:00AM	TriLink BioTechnologies Solidifies IP Position with Awarded Patents for CleanCap Capping Technology in China and Canada (Business Wire)
Feb-13-24 08:30AM	Dyadic and Cygnus Technologies Announce Partnership To Provide C1 HCP ELISA Assay to Enhance Quality Assurance in Biomanufacturing (GlobeNewswire) -6.55%
Feb-11-24 05:00PM	3 Doomed Biotech Stocks to Dump Before They Dive: February 2024 (InvestorPlace)
Feb-07-24 06:46AM	Will Maravai LifeSciences Holdings (MRVI) Pipeline Start to Bear Fruit? (Insider Monkey)
Jan-29-24 08:00AM	Maravai LifeSciences To Host Earnings Conference Call on Thursday, February 22, 2024 (GlobeNewswire)
05:27AM	Loading…
Dec-18-23 05:27AM	Bank of America Pounds the Table on These 3 Buy-Rated Stocks (TipRanks)
Nov-24-23 08:39AM	Are Options Traders Betting on a Big Move in Maravai LifeSciences (MRVI) Stock? (Zacks)
Nov-09-23 08:15AM	Maravai LifeSciences Announces November 2023 Investor Conference Schedule (GlobeNewswire)
Nov-08-23 04:02PM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2023 Earnings Call Transcript (Insider Monkey) -31.69%
12:00AM	Maravai LifeSciences (MRVI) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-07-23 04:49PM	Maravai LifeSciences Holdings Inc (MRVI) Reports Q3 2023 Financial Results Amidst Market Realignment (GuruFocus.com)
04:05PM	Maravai LifeSciences Reports Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 06:47AM	TriLink BioTechnologies Expands Capabilities with Launch of Analytical Sciences Center of Excellence (Business Wire)
Oct-20-23 12:08PM	12 Cheap Biotech Stocks Smart Investors Are Piling Into (Insider Monkey)
Oct-17-23 08:15AM	Maravai LifeSciences To Host Earnings Conference Call on Tuesday, November 7, 2023 (GlobeNewswire)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
08:15AM	Maravai LifeSciences Hosts 2023 Investor R&D Day (GlobeNewswire)
Sep-25-23 08:49AM	PetIQ (PETQ) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Sep-19-23 09:31AM	Maravai LifeSciences Chief Innovation Officer Kate Broderick Named to 2023 PharmaVoice 100 (GlobeNewswire)
Sep-05-23 04:15PM	Maravai LifeSciences to Host 2023 Investor R&D Day (GlobeNewswire)
08:15AM	Loading…
Aug-23-23 08:15AM	Cygnus Technologies Receives 2023 R&D 100 Award for MockV® RVLP Kit (GlobeNewswire)
Aug-22-23 08:14AM	11 Most Undervalued Biotech Stocks to Buy According to Analysts (Insider Monkey)
Aug-09-23 04:15PM	Maravai LifeSciences Announces August 2023 Investor Conference Schedule (GlobeNewswire)
06:03AM	What Does The Future Hold For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
Aug-08-23 06:20AM	15 Worst Performing Biotech Stocks in 2023 (Insider Monkey)
01:30AM	Maravai LifeSciences (MRVI) Q2 2023 Earnings Call Transcript (Motley Fool)
Aug-07-23 04:05PM	Maravai LifeSciences Reports Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-27-23 04:05PM	Maravai LifeSciences Announces Completion of Planned CEO Leadership Transition (GlobeNewswire)
Jul-24-23 04:05PM	Maravai LifeSciences To Host Earnings Conference Call on Monday, August 7, 2023 (GlobeNewswire)
Jul-20-23 04:05PM	Maravai LifeSciences Announces Appointment of New Director to the Board (GlobeNewswire)
Jul-18-23 08:37AM	ZimVie Inc. (ZIMV) Stock Jumps 20.6%: Will It Continue to Soar? (Zacks)
Jul-16-23 08:51AM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? (Simply Wall St.)
Jun-06-23 08:00AM	Congressman Scott Peters Tours Maravais RNA manufacturing facility (GlobeNewswire)
May-24-23 08:10AM	TriLink BioTechnologies® Announces Manufacturing Capabilities Expansion as mRNA Manufacturing Facility Nears Completion (Business Wire)
May-09-23 12:49PM	Q1 2023 Maravai LifeSciences Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -13.02%
08:00AM	TriLink BioTechnologies Introduces Latest mRNA Capping Technology: CleanCap® M6 analog (GlobeNewswire)
01:00AM	Maravai LifeSciences (MRVI) Q1 2023 Earnings Call Transcript (Motley Fool)
May-08-23 05:35PM	Maravai LifeSciences Holdings, Inc. (MRVI) Lags Q1 Earnings and Revenue Estimates (Zacks)
04:05PM	Maravai LifeSciences Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-17-23 04:15PM	Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023 (GlobeNewswire)
Mar-28-23 05:00PM	Maravai LifeSciences Releases 2022 Environmental, Social and Governance (ESG) Report (GlobeNewswire)
Mar-20-23 06:50AM	5.6% earnings growth over 1 year has not materialized into gains for Maravai LifeSciences Holdings (NASDAQ:MRVI) shareholders over that period (Simply Wall St.)
Mar-13-23 08:45AM	2 Top Biotech Stocks to Buy In March and Hold Forever (Motley Fool)
Mar-09-23 06:40AM	Will Maravai LifeSciences Holdings (MRVI) be a Long-Term Compounder in Your Portfolio? (Insider Monkey)
Mar-08-23 08:00AM	Maravai LifeSciences Announces March 2023 Investor Conference Schedule (GlobeNewswire)
Mar-04-23 08:19AM	13 Most Undervalued Healthcare Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-02-23 08:45AM	Don't Miss Out on These 2 Undervalued Stocks With Huge Growth Potential (Motley Fool) +5.34%
Feb-27-23 05:35AM	Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Shares Could Be 28% Below Their Intrinsic Value Estimate (Simply Wall St.)
Feb-23-23 01:00AM	Maravai LifeSciences (MRVI) Q4 2022 Earnings Call Transcript (Motley Fool) +8.17%
Feb-22-23 05:55PM	Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q4 Earnings Estimates (Zacks)
04:05PM	Maravai LifeSciences Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire)
Feb-16-23 10:01AM	Earnings Preview: Vapotherm (VAPO) Q4 Earnings Expected to Decline (Zacks)
Feb-15-23 10:00AM	Earnings Preview: Maravai LifeSciences Holdings, Inc. (MRVI) Q4 Earnings Expected to Decline (Zacks) +7.63%
Feb-14-23 04:33PM	11 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Feb-07-23 10:15AM	2 Healthcare Companies That Could Be Acquired Within 5 Years (Motley Fool)
Feb-06-23 07:34AM	Are Strong Financial Prospects The Force That Is Driving The Momentum In Maravai LifeSciences Holdings, Inc.'s NASDAQ:MRVI) Stock? (Simply Wall St.)
Feb-01-23 08:00AM	Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023 (GlobeNewswire)
Jan-27-23 09:37AM	3 Great Growth Stocks Down 20% or More to Buy Now (Motley Fool)
Jan-16-23 08:30AM	3 Biopharma Stocks That Could Help Make You a Fortune (Motley Fool)
Dec-12-22 09:53AM	10 Best Medical Stocks Under $20 (Insider Monkey)
Dec-01-22 04:01PM	Maravai LifeSciences Announces Updated CEO Leadership Transition Plans (GlobeNewswire)
Nov-28-22 08:30AM	2 Biotech Stocks You Can Buy and Hold for the Next Decade (Motley Fool)
Nov-16-22 05:05PM	Maravai LifeSciences Named to the 2022 Deloitte Technology Fast 500 List of Fastest-Growing Companies in North America (GlobeNewswire)
Nov-09-22 07:16AM	Maravai LifeSciences Holdings Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) -5.47%
Nov-07-22 04:10PM	New Kit Predicts Retroviral Particle Clearance in Biopharmaceutical Manufacturing (GlobeNewswire) -8.70%
Nov-06-22 07:30AM	Things Look Grim For Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) After Today's Downgrade (Simply Wall St.)
Nov-03-22 04:05PM	Maravai LifeSciences Announces November and December 2022 Investor Conference Schedule (GlobeNewswire) -5.53%
12:30AM	Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript (Motley Fool)
Nov-02-22 06:15PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q3 Earnings Beat Estimates (Zacks) -6.51%
04:05PM	Maravai LifeSciences Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-29-22 08:45AM	This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why (Motley Fool)
Oct-24-22 10:39AM	This Pandemic Star Is Embroiled in CEO Drama (TheStreet.com)
Oct-19-22 08:10AM	Maravai LifeSciences Temporarily Reinstates Carl Hull as CEO Amidst Pending Noncompetition Litigation (GlobeNewswire) -13.18%
Oct-18-22 04:15PM	Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022 (GlobeNewswire)
Oct-13-22 08:32PM	Time to Bottom Fish? 3 Strong Buy Stocks That Are Down Over 40% This Year (TipRanks)
Oct-08-22 08:28AM	Maravai LifeSciences Holdings (NASDAQ:MRVI) shareholders have lost 52% over 1 year, earnings decline likely the culprit (Simply Wall St.)
Oct-06-22 11:28AM	Did Maravai LifeSciences Deserve to Sell Off on CEO Transition? (TheStreet.com)
Oct-03-22 04:05PM	Maravai LifeSciences Announces CEO Leadership Transition (GlobeNewswire)
Sep-13-22 08:00AM	TriLink BioTechnologies, Part of Maravai LifeSciences, Expands its mRNA Raw Material Offering with the First GMP-grade Modified Nucleoside-Triphosphate Product (GlobeNewswire)
Aug-29-22 01:47PM	Declining Stock and Solid Fundamentals: Is The Market Wrong About Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)? (Simply Wall St.)
Aug-17-22 08:42AM	Do Options Traders Know Something About Maravai LifeSciences (MRVI) Stock We Don't? (Zacks)
Aug-15-22 04:05PM	Maravai LifeSciences Announces September 2022 Investor Conference Schedule (GlobeNewswire)
Aug-05-22 01:30PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2022 Earnings Call Transcript (Motley Fool)
10:30AM	3 of the Best Bear Market Buys for August (Motley Fool)
Aug-04-22 05:55PM	Maravai LifeSciences Holdings, Inc. (MRVI) Q2 Earnings and Revenues Beat Estimates (Zacks)
04:51PM	CORRECTION: Maravai Lifesciences Reports Second Quarter 2022 Financial Results (GlobeNewswire)
04:03PM	Maravai Lifesciences Reports Second Quarter 2022 Financial Results (GlobeNewswire)
Aug-02-22 10:00AM	Analysts Estimate Perrigo (PRGO) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-28-22 10:03AM	Maravai LifeSciences Holdings, Inc. (MRVI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Jul-23-22 05:58AM	3 Beaten-Down Stocks That Could Soar in the Second Half of 2022 (Motley Fool)

Maravai Lifesciences Holdings, Inc. is a life sciences company. It is engaged in providing products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. The firm operates through the following segments: Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment focuses on the manufacturing and sale of highly modified nucleic acids products to support the needs of customers' research, therapeutic and vaccine programs. The Biologics Safety Testing segment focuses on manufacturing and selling biologics safety and impurity tests and assay development services that are utilized by its customers in their biologic drug manufacturing activities. The company was founded by Eric Tardif and Carl W. Hull in March 2014 and is headquartered in San Diego, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MRVI

Maravai LifeSciences Holdings Inc

Upgrade your FINVIZ experience